Identifying barriers and utility of obtaining ambulatory blood pressure monitoring in a pediatric chronic kidney disease population

BMC Pediatrics

Research

Aris Oates¹  Sanober Sadiq¹  Elizabeth Black² 

[1] Department of Pediatrics, University of California, San Francisco, 550 16th Street, 4th Floor, 3214, 94143, San Francisco, CA, USA;Department of Pediatrics, University of California, San Francisco, 550 16th Street, 4th Floor, 3214, 94143, San Francisco, CA, USA;Department of Pediatrics, University of California, San Francisco – Fresno, Fresno, CA, USA;

关键词: Chronic kidney disease;    Hypertension;    Ambulatory blood pressure monitoring;    Masked hypertension;    White coat hypertension;   

DOI  :  10.1186/s12887-023-04304-7

 received in 2023-01-12, accepted in 2023-09-09,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundHypertension is a prevalent complication of Chronic Kidney Disease (CKD) and Ambulatory Blood Pressure Monitoring (ABPM) is the gold standard for diagnosis. The aim of our study was to assess the usefulness of obtaining ABPM and to identify barriers to ABPM in this pediatric patient population.MethodIn this retrospective analysis of patients with CKD stage 3–5 who were seen in one academic medical center’s outpatient Pediatric Nephrology clinics between 2018 and 2021, we performed logistic regression to evaluate for associations between demographic factors and odds of having an ABPM.ResultAmong 96 patients included in the study, 48 patients carried a diagnosis of hypertension. 31 patients had ABPM performed with usable data. In those who had ABPM done, 21 had normotension and 10 had undertreated hypertension. Our study also showed 1 had masked hypertension and 5 had white coat hypertension or effect. We did not find a statistically significant difference in those who did or did not undergo ABPM evaluation based on gender, previous diagnosis of hypertension, distance from clinic, language preference, or racial or ethnic identity.ConclusionABPM is a useful tool in our CKD population for the diagnosis and management of hypertension. We did not identify specific barriers to ABPM in our CKD population, and there were no differences in patients who obtained ABPM when looking at specific demographic and disease characteristics. Given these findings, we recommend focusing on areas of future improvement in spheres of patient and provider education as well as better quantification using surveys to further illuminate barriers.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023